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nderstanding how the brain functions requires
both a detailed comprehension of its anatomical organi-
zation and of the properties of neurons and their com-
munications. A review of the findings on establishing
how the brain is organized and on its fundamental prop-
erties allows us to contemplate the major progress made
and the magnitude of the road that still lies ahead. The
first layout of brain organization was provided by stud-
ies relying on the abnormalities resulting from lesions of
the neuronal tissue, caused either by accidents or by
hemorrhages, such as that of the area identified by Paul
Broca (1824-1880). The design of the first brain atlas pro-
vided a building block in our comprehension of brain
structure, with the definition of the Brodmann areas and
the design of the first brain atlas (1909). Progress in the
knowledge of the fine structure of the brain was marked
by the appearance of detailed anatomies, with the
description of neurons and their projections carried out
by S. Ramón Y Cajal (1852-1934). In spite of the
progress made possible by the refinement of brain
atlases, and then confirmed by functional magnetic res-
onance imaging (fMRI), our knowledge of brain func-
tion and dysfunction is only slowly progressing.
Developments in the understanding the functional prop-
erties of neurons and their communications was marked
by a series of fundamental steps. The first was the con-
troversy between the Italian physicist Alessandro Volta
(1745-1827) and his compatriot the physician Luigi
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Continuing to discover how the brain works is one of the
great challenges ahead of us. Although understanding the
brain anatomy and its functional organization provided a
first and indispensable foundation, it became clear that a
static view was insufficient. To understand the complexity
of neuronal communication, it is necessary to examine the
chemical nature of the neurotransmission and, using the
example of the acetylcholine receptors, follow the differ-
ent layers of networks that can be distinguished. The nat-
ural alkaloid nicotine contained in tobacco leaves acts as
an agonist with a subclass of acetylcholine receptors, and
provides an interesting tool to approach brain functions.
Analysis of the nicotinic acetylcholine receptors, which are
ligand gated channels, revealed that these receptors are
expressed at different critical locations on the neurons
including the synaptic boutons, neurites, cell bodies, and
even on the axons. These receptors can modulate the
activity at the microcircuit synaptic level, in the cell pro-
cessing of information, and, by acting on the velocity of
action potential, the synchrony of communication
between brain areas. These actions at multiple levels of
brain organization provide an example of the complexity
of brain neurocircuitry and an illustration of the relevance
of this knowledge for psychiatry.  
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Galvani (1737-1798), who posited for the first time the
existence of “animal electricity.” Proper studies of the
electrical properties of neurons had, however, to await
the development of electronics, and it was only in 1952
that Alan Hodgkin and Aldous Huxley established the
theory explaining action potential properties. It was
indispensable to understand how neurons, which are the
building blocks of our brain, communicate, and how the
electrical signal is transmitted from one cell to another.
A contribution to our understanding of neurotransmis-
sion was made by the French physiologist Claude
Bernard (1813-1878) with his postulate about the exis-
tence of a chemical transmitter that relayed the infor-
mation between the nerve and the muscle. He based his
hypothesis on the observation that transmission of the
nerve impulse, which normally provokes the contraction
of the muscle, was blocked by the plant extract tubocu-
rare, while the muscle still responded to direct electrical
stimulation. Subsequently, Otto Loewi (1873-1961) iden-
tified that stimulation of the vagus nerve caused the
release of a soluble factor that slowed down the heart-
beat. First termed “vagus stoff” this substance was soon
identified as acetylcholine, and it was found that this
molecule activated the G-coupled muscarinic and the
ionotropic nicotinic receptors, such as those expressed
at the neuromuscular junction. The work of John Eccles
(1903-1997) and Bernard Katz (1911-2003) with Ricardo
Miledi provided the necessary steps to finally develop-
ing the general principles explaining synaptic transmis-
sion.
From these studies it became clear that brain function
resulted from the electrical activity of neurons measured
by the electroencephalogram (EEG). These observa-
tions confirmed the relevance of neuronal communica-
tions both within and across brain areas. As a conse-
quence, different levels of complexities must be
considered, with, on one hand the importance of micro-
circuits, which are restricted to the level of a group of
neurons within a given area, and on the other hand the
contribution of macrocircuits allowing communication
between brain areas or brain hemispheres. As we shall
see, nicotinic acetylcholine receptors significantly con-
tribute to both micro- and macrocircuit levels. In this
review we shall examine how acetylcholine can modu-
late brain function. While this neurotransmitter has a
dual action at the G-coupled muscarinic and ionotropic
nicotinic receptors, we shall restrict our analysis to lig-
and gated ion channels.
Nicotine and nicotinic acetylcholine receptors
Ever since the beginning of humanity, mankind has
experienced the effect of food or natural substances on
the mental state, and use or abuse of psychotropics were
known even in the most ancient cultures. The mecha-
nisms by which psychotropic substances exerted their
effects were totally unknown; they indirectly showed the
interaction of a compound with the brain function.
Plants are endowed with many alkaloids, serving differ-
ent purposes and in certain cases acting as natural insec-
ticides.
1The discovery of America marked the introduc-
tion into Europe of new plant species, among them the
tobacco plants. Nicotine was named after the French
physician Jean Nicot (1530-1600) who used it to treat
queen Catherine de Medici’s headache. Tobacco usage
was progressively extended, becoming widely consumed
by about half of the population. That smoking tobacco
can become a central issue for many is illustrated by sen-
tences such as the one by Mark Twain (1835-1910): “If
I cannot smoke in heaven, then I shall not go.” While it
had been recognized that at high concentrations nicotine
could affect the neurotransmission at the neuromuscu-
lar junction and the conduction of the nerve impulse in
ganglia, the action of nicotine on the central nervous sys-
tem remained for a long time a theme of controversy.
The development of molecular biology and the identifi-
cation of an entire family of genes encoding for nicotinic
receptor subunits settled this controversy with the
demonstration of the broad expression of nicotinic
acetylcholine receptors in the central nervous system.
Today seventeen genes encoding for the muscle and
neuronal nicotinic acetylcholine receptors (nAChRs)
have been identified in mammals.
2 Muscle and neuronal
nAChRs result from the assembly of five subunits
around an axis of pseudosymmetry. At their simplest
neuronal nAChRs are homomeric (constituted from five
identical subunits
3) while the more complex forms are
heteromeric, composed of at least one α and one β sub-
type (reviewed in refs 2,4). Combination of various αs
and βs allow for a large number of receptor subtypes to
be formed. The physiological and pharmacological prop-
erties of the receptors depend upon both the α and β
subunits expressed in the functional complexes.
Analysis of human, mouse, and other animal genomes
revealed that nicotinic acetylcholine receptors have been
conserved throughout evolution, and that ancestor genes
appeared early, in the simplest forms of life. Indeed,
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more nicotinic receptor genes have been identified in
mollusks than in vertebrates, indicating that these recep-
tors may play an even larger role in invertebrates. The
observation of this high degree of conservation called
for further reflections about the role of these receptors
in brain activity, and forced the design of new experi-
ments to examine their function and dysfunction in the
central nervous system. Labeling experiments carried
out with different probes revealed that nicotinic recep-
tors are widely expressed both in the cortex, white mat-
ter, and in groups of neurons in brain nuclei.
5 For exam-
ple, intense labeling was observed in the fasciculus
retroflexus, which connects the habenula to the interpe-
duncular nuclei.
6 The development of novel molecules,
such as A-85380, which label with high affinity the major
brain α4β2 nicotinic receptors, opened up the possibility
of measuring receptor distribution using positron emis-
sion tomography.
7-9 Confirming the high degree of recep-
tor expression in the thalamus, these studies were rapidly
extended to pathological conditions.
5,10,11 Importantly, sig-
nificant labeling was also observed in the white matter.
5
While providing further evidence about the importance
of the nicotinic receptors they also highlight the need for
more precise mapping of the receptor distribution with
ligands of the receptor subtypes in normal or patholog-
ical conditions. Obtaining precise mapping of receptor
distribution becomes indispensable for understanding
the role of nAChRs in brain function. Progress toward
this goal has, however, been hampered by the absence of
selective antibodies, as shown by studies carried out in
knockout animals.
12
The isolation of the genes encoding for the nicotinic recep-
tors allowed their reconstitution in host systems and, con-
sequently, their functional characterization. Experiments
carried out in Xenopus oocytes or in cell lines expressing
the human receptors confirmed that these ligand gated
channels are permeable to cations, causing a depolariza-
tion of the cell when they are activated.
2,13,14The ionic selec-
tivity of nAChRs differs markedly in function of the recep-
tor subtype. For example, while the muscle receptors
display a very low permeability to the divalent calcium
ions, the homomeric α7 nAChRs present a higher perme-
ability to calcium than sodium.
15Activation of α7 nAChRs
was shown to increase the intracellular calcium concen-
tration and, for receptors expressed presynaptically, indi-
rectly causing neurotransmitter release.
Allowing for the first time the evaluation of the proper-
ties of human receptors in vitro, these studies also
revealed some of their distinct properties. Nicotinic
acetylcholine receptors are characterized by the fact that
the amplitude of their response depends upon the mem-
brane potential of the cell, causing a physiological effect
only when the cell is hyperpolarized. This voltage depen-
dence, or inward rectification, will contribute to neuron
function in processes such as coincidence detection of
different events.
13,14Another, very important, property of
the nicotinic receptors is their high permeability to cal-
cium. The most calcium-permeable subtype is the homo-
meric α7 receptor.
15,16The calcium influx caused by acti-
vation of the α7 nicotinic receptors is sufficient to trigger
different cellular effects and was shown, in presynaptic
boutons, to control or modulate the release of neuro-
transmitters.
2,17-21 Numerous examples have now been
provided, confirming the physiological relevance of nico-
tinic receptors in controlling the synaptic transmission
of synapses in which the signal is mediated by other neu-
rotransmitters.
In natural conditions, activation of nicotinic acetyl-
choline receptors is caused by the release of acetyl-
choline. It was, however, shown that α7 receptors are
also activated by high concentrations of choline and it
was proposed that choline released by the breakdown of
acetylcholine by acetylcholine esterase might play a role
in controlling these receptors' activity.
4
Modulation at the receptor level
Functional properties of the nicotinic cholinergic sys-
tem are finely tuned by different mechanisms, including
receptor phosphorylation and allosteric modulations.
For example, it was shown that the level of phosphory-
lation of the α7 receptors controls the amplitude of the
acetylcholine-evoked current without changing the
response time course.
22 A first example of allosteric
modulation of the α7 nicotinic receptors was provided
with the observation of the effects caused by the
anthelmintic drug ivermecticine.
23 Since then several
molecules have been shown to modulate α7 receptor
activity, with the most powerful effects caused by PNU-
120596.
24 Moreover, it was shown that α7 receptor activ-
ity is modulated by endogenous polypeptides.
25-29
Modulation of receptor function is not restricted to α7
receptors, but has also been observed for heteromeric
receptors. Divalent cations, such as calcium and zinc, can
bind in the N-terminal extracellular domain of the
receptors and modulate their activity. Exposure to zinc,
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in the µM range, potentiates the α4β2 or α4β4 receptor
subtypes whereas it inhibits the α3β2 receptors, further
exemplifying the pharmacological complexity associ-
ated with heteromeric receptor combinations.
30
Recalling that zinc is released during synaptic trans-
mission, such modulation is supposed to provide an
additional mechanism by which cells can regulate recep-
tor function. Potentiation of the major brain α4β2 sub-
type by 17-β-estradiol provides still another example of
nicotinic receptor modulation.
31
Importance of nAChRs for brain microcircuits
Since the discovery by S. Ramón Y Cajal of the struc-
tural organization of the cortical layers, it has become
evident that brain function depends upon the activation
of small neuronal networks, the activity of which is trans-
mitted to the next layer of integration. The description
of column activities in the visual cortex by D. Hubel and
T. Wiesel in 1959 confirmed the hypothesis formulated
by Cajal. The cortical organization and columns con-
verge on the pyramidal cells from layer 6 that project
their axons toward other brain areas. Often seen as a
computational unit with recurrent feedback, the pyra-
midal cell receives converging information from its api-
cal tuft and from dendrites localized on its cell body. An
important particularity of the pyramidal cell is the back
propagation of the action potential from the cell body
along the proximal dendrite.
32,33This process was shown
to enhance or inhibit the signals transmitted by the api-
cal tuft, and provides an exquisite mechanism for the
integration of multiple inputs (Figure 1). This mechanism
depends on the firing rate of action potentials in the
axon hillock, as well as synchrony of activities, and it was
shown that back propagation can be disrupted by the
activation of ion channels expressed along the principal
dendrite.
34,35
Nicotinic receptors are broadly expressed in the cortical
area with some subtypes such as α7 receptors prepon-
derantly expressed in presynaptic areas, whereas het-
eromeric receptors are expressed on cell bodies, main
dendrites, axons, etc.
36-38 Nicotine exposure has been
shown to enhance attention and working memory by
activating nicotinic receptors. Although our under-
standing of these effects remains limited, nicotine
increases the threshold for synaptic spike-timing-
dependent-potentiation (STDP) in layer 5 of the pre-
frontal cortex of the mouse.
39 Systemic administration of
nicotinic agonists such as SSR180711 or PNU-282987
has shown beneficial cognitive effects and reversal of
amphetamine-induced deficits, thought to be mediated
by acting at the microcircuit cortical level.
40,41
Importantly, cholinergic projections that diffusely inner-
vate the cortex are thought to make en-passant connec-
tions in the area of the principal dendrite of the pyrami-
dal cells from layer 5 and 6.
42 Activation of these fibers
causes the release, in a volumic manner, of acetylcholine
that will diffuse and slowly activate receptors expressed
on the principal dendrite. Opening of the nicotinic
acetylcholine receptors reduces the membrane resis-
tance and attenuates signals coming from the apical den-
drites. This reduction of the influence of the apical tuft
and external layer contributions modifies the integration
and “computation” of the pyramidal cell. Altogether,
acetylcholine can act at different levels ranging from
synaptic release, signal transmission, and resting mem-
brane potential to modulate microcircuit activity.
Importance of nAChRs in brain macrocircuits
Communication between brain areas and between
hemispheres relies on the conduction of the action
potential along the axons. Brain axons can be myeli-
nated or unmyelinated, with the latter displaying the
slowest conduction velocity. Importantly, however, con-
duction velocity of myelinated axons is limited by the
diameter of the fibers and ranges between 3.5 m/s in the
visual cortex to at most 29 m/s in the thalamocortical
Figure 1. Schematic representation of pyramidal cells with the en-pas-
sant fibers. Activation of the nicotinic receptors located along
the main dendrite produce a short circuit of the signals com-
ing from the apical tuft.
Apical tuft
En-passant fibers
Pyramidal cells
Axons
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43-45This implies that for a distance of about 10
cm the propagation time ranges between 3.5 and 28 ms
which is not negligible. Further complexity when con-
sidering the velocity of conduction is added when tak-
ing into account the different parameters dictating this
velocity. Two determinant parameters are: (i) the phys-
ical properties of the axon with its diameter and space
constant (the distance at which an electrical signal is
attenuated by a factor of 2); and (ii) the membrane
properties at the nodes of Ranvier. A wider expression
of sodium channels in the node of Ranvier yields a
larger inward current during the action potential and
a faster velocity of conduction. This is well illustrated by
the slowing of the conduction velocity observed during
local anesthesia
46 by a compound such as lidocaine.
Conduction velocity at the node of Ranvier also
depends on the presence of additional ion channels.
Activation of channels causing an increase in the mem-
brane conductance reduces the efficiency of the sodium
channel effects. Activation of channels causing a depo-
larization of the node of Ranvier progressively inacti-
vates the sodium channels, yielding a reduction in the
sodium current and of the amplitude of the action
potential. As it was shown that nAChRs are expressed
at axonal level and are present in human white mat-
ter,
2,5,6 activation of these cationic receptors is expected
to modulate conduction velocity. In agreement with this
hypothesis, exposure to cholinergic drugs was shown to
reduce conduction velocity of the habenulointerpedun-
cular pathway.
47This might be of clinical relevance since
lesions of this pathway in rats produce anxiety and
hyperlocomotor activity.
48
Brain circuit dysfunction
In spite of the major progress made in brain imaging, our
knowledge about the timing of propagation and rele-
vance of brain activities remains limited. While the use
of fMRI has increased our knowledge about brain areas
involved in a given set of functions, these techniques
have a temporal resolution that is orders of magnitudes
too slow with respect to the actual brain processes.
Electroencephalography with a large number of scalp
electrodes, or in some cases, with deep brain electrodes,
provides a much better time resolution but its usefulness
remains limited by the issue of spatial resolution.
Data obtained by fMRI have shown that even brain
functions that are thought to be simple require the con-
tribution of activities from several areas. As communi-
cation between these areas must propagate along the
small axon fibers from cortical neurons, modulation of
the conduction velocity is expected to change the syn-
chronicity of signals.
Although our knowledge of the exact computational
tasks of specific brain areas, such as the hippocampus
and the entorhinal cortex, or the prefrontal cortex and
the thalamus, is limited, it is clear that a change in syn-
chrony can lead to a different outcome of the function.
Taking for example the interpretation of language and
phonation that are known to involve the Wernicke and
Broca areas, these distinct cortical structures are heav-
ily connected by the arcuate fasciculus. Alteration of
arcuate fasciculus function can lead in the extreme to the
type of aphasia known as conduction aphasia. The
importance of the arcuate fasciculus clearly illustrates
the relevance of conduction of brain activity between
brain areas. An even higher degree of complexity is eas-
ily understood when imaging the brain areas involved in
the recognition of a voice calling a given name, and the
need to recognize our own name before reacting and
answering “yes I am here.”
Several psychiatric disorders ranging from schizophre-
nia and chronic depression to post-traumatic stress dis-
order have been associated with white-matter defects.
49
While some of these conditions may correlate with
abnormalities in the development of brain connectivity,
others are probably associated with temporary or suc-
cessively permanent impairment of the white matter
functionality. Proper timing of electrical activity in dif-
ferent areas of the brain is certainly imperative for the
overall function of the brain. For example it can be fore-
seen that associative functions rely on the proper timing
of electrical activities from many distinct brain areas.
Disruption of synchrony between single cells in the hip-
pocampal and prefrontal cortex in an animal model was
recently shown to alter acquisition tasks that are thought
to be altered in schizophrenia.
50 Moreover, in humans,
using complex electroencephalographic techniques, it
was shown that successful memory formation is pre-
dicted by a tight coordination of spike timing and theta
oscillation (4 to 10 Hz).
51While confirming the need for
accurate timing of signal transmission these data high-
light the potential modulatory role that acetylcholine
can play by adjusting the velocity conduction between
brain areas, and therefore the time correlation between
signals from different origins. 
Nicotinic cholinergic system neurocircuitry - Bertrand Dialogues in Clinical Neuroscience - Vol 12 . No. 4 . 2010
467
PAGES_11_AG_1039_BA.qxd:DCNS#45  3/12/10  12:15  Page 467Nicotinic receptors and brain dysfunction
Examining the correlation between genetic alterations and
brain dysfunctions can provide a further understanding of
the role of a given receptor set. Analysis of genetically
transmissible forms of epilepsy revealed that a particular
form of nocturnal epilepsy was associated with a variation
in CHRNA4, the gene encoding for the α4 subunit of the
nicotinic acetylcholine receptors.
52This initial finding was
soon followed by the description of other mutations in this
gene and the contribution of nicotinic acetylcholine recep-
tors was confirmed with the identification of additional
mutations in CHRNB2, the gene encoding for the β2 sub-
unit that is indispensable to produce functional receptors
(reviewed in ref 53). The autosomal dominant nature of
the mutation, together with the characteristics of these
epilepsies, which are nocturnal and have a frontal lobe ori-
gin, lead to the nomenclature of this syndrome as “auto-
somal dominant nocturnal frontal lobe epilepsy” or
ADNFLE. Importantly, all mutations identified so far
yield a gain of function of the α4β2 nicotinic acetylcholine
receptors. This suggests that inhibition of these receptors
is expected to reduce the severity of the symptoms. Indeed,
epilepsies can be controlled by low concentrations of the
antiepileptic drug carbamazepine (CBZ) in many patients.
In some families this treatment remains, however, ineffi-
cacious. Studies of control and mutated nicotinic acetyl-
choline receptors corresponding to these different fami-
lies revealed in most cases a high sensitivity to CBZ, which
inhibits the α4β2 nicotinic acetylcholine receptors, whereas
for other mutations sensitivity to CBZ was reduced.
54-56
A more detailed examination of the patient conditions
in different families presenting ADNFLE revealed that
some mutations are also associated with significant cog-
nitive impairments.
53
Labeling studies performed in monkey and rat brain have
revealed significant differences in the level of expression
of specific subunits. For example it was shown that the α2
subunit is largely expressed in the prefrontal cortex of the
monkey brain, whereas its level of expression is much
lower in the rat.
57 The discovery of a mutation in the
CHRNA2, the gene encoding for the α2 subunit of the
nicotinic acetylcholine receptor, and its association with
one form of genetically transmissible epilepsy opened a
new chapter in our understanding of the link between the
cholinergic system and neurological diseases.
58,59
These data are in good agreement with the hypothesis
of the crucial role played by the cholinergic system in
cognitive functions. A progressive decline in cholinergic
tone has been proposed to correlate with the cognitive
impairments observed in patients with Alzheimer dis-
ease. To compensate for the loss of cholinergic tone,
cholinesterase inhibitors has been introduced in clinical
practice and, more recently, nicotinic agonists have been
studied in clinical trials. These clinical trials represent the
first step toward the design of additional studies aimed
at further reducing or compensating for the effects of
low acetylcholine levels in the brain.
Conclusions
Natural alkaloids, such as nicotine, can have multiple
effects on our body, and these have been recognized
since the earliest times. A long series of discoveries
was, however, necessary to obtain enough information
about the effects that such natural alkaloid have on
central nervous system function. The identification of
the genes encoding for neuronal nicotinic acetyl-
choline receptors marked a turning point in our
approaches to the functional properties of the brain,
and led to the characterization of receptors that are
activated by low concentrations of nicotine. These
receptors, which are permeable to cations, cause mul-
tiple effects depending upon their cellular and subcel-
lular localization. Analyses of the receptor distribution
and functions at the microcircuit level indicate that
these receptor can modulate the release of neuro-
transmitters, affecting the signal integration and pro-
cessing that is taking place at the cortical level.
Receptors expressed in the white matter have been
shown to modulate the velocity of propagation of the
action potential and thereby modify the timing of
activity between brain areas. In view of the critical role
played by the synchronization between different brain
areas in cognitive tasks and learning, it appears that
control of the velocity of action potential transmission
is determinant for high-level brain functions. Genetic
analysis and associations observed between mutations
in nicotinic acetylcholine receptor genes and neuro-
logical disorders has confirmed the relevance of nico-
tinic receptors in humans, and pave the way for future
pharmacogenomic studies. ❏
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Circuitos neuronales del sistema colinérgico
nicotínico
Uno de los grandes desafíos que se nos presenta es
el descubrimiento del funcionamiento íntimo de
nuestro cerebro. Si bien el análisis de la anatomía
del sistema nervioso y de su organización estructu-
ral permite establecer los fundamentos indispensa-
bles; también es claro que una visión estática resulta
insuficiente. Para comprender la complejidad de las
comunicaciones neuronales nos debemos abocar a
la naturaleza de la neurotransmisión y analizar, por
ejemplo, el funcionamiento de un sistema de neu-
rotransmisión como es la acetilcolina. La nicotina,
que es el alcaloide natural contenido en las hojas de
tabaco, activa un subtipo de receptores de acetilco-
lina que son canales ionotrópicos. El análisis de estos
canales activados por la nicotina demuestra que
ellos se expresan en diferentes zonas críticas de las
neuronas, incluyendo los botones sinápticos, los
cuerpos celulares e incluso los axones. La activación
de esos receptores permite modular la transmisión
sináptica, la actividad de los microcircuitos neuro-
nales como también la velocidad de propagación de
los potenciales de acción en la sustancia blanca y
además modula la sincronía entre diferentes áreas
cerebrales. Estos niveles de acción proporcionan un
buen ejemplo de la importancia de la plasticidad de
los circuitos neuronales que participan en la elabo-
ración de las señales cerebrales. 
Circuits neuronaux du système nicotinique
cholinergique
Découvrir le fonctionnement intime de notre cer-
veau représente l’un des grands défis que nous
devons franchir. Si l’analyse de l’anatomie du sys-
tème nerveux et de son organisation structurelle ont
permis d’établir des fondements indispensables, il
est clair qu’une vue statique reste cependant insuf-
fisante. Pour comprendre la complexité des com-
munications neuronales, nous devons nous pencher
sur la nature de la neurotransmission en analysant,
par exemple, le fonctionnement d’un système de
neurotransmetteur comme l’acétylcholine. La nico-
tine qui est un alcaloïde naturel contenu dans les
feuilles de tabac active un sous-type de récepteurs à
l’acétylcholine qui sont des canaux ionotropes.
L’analyse de ces canaux activés par la nicotine
démontre qu’ils sont exprimés dans différentes
zones critiques des neurones incluant les boutons
synaptiques, les neurites, les corps cellulaires ou
encore les axones. L’activation de ces récepteurs per-
met de moduler la transmission synaptique, l’acti-
vité de microcircuits neuronaux ainsi que la vitesse
de propagation des potentiels d’action dans la
matière blanche et module la synchronie entre dif-
férentes aires du cerveau. Ces niveaux d’action four-
nissent un bon exemple de l’importance de la plas-
ticité des circuits neuronaux qui participent à
l’élaboration des signaux cérébraux.
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